The team aims to bring this cutting-edge technology to preclinical stroke research to gain a better understanding of the mechanisms of SD initiation and their involvement in worsening stroke severity. This work will be a crucial first step in the maturity of this technology towards future clinical translation where they anticipate that it will greatly facilitate management of patients in the neuro-intensive care units.

Funding has been awarded through the dual-award PhD programme between the University of Melbourne and University of Manchester. The dual-award scheme brings together research teams between the two institutions with a PhD student assigned to each. This is a highly competitive scheme with just six dual awards (twelve students) made across both Universities in all disciplines. For our researchers to secure two of these awards is therefore a fantastic achievement.